SLA Pharma's EPA free fatty acid reduces colonic polyps
This article was originally published in Scrip
Executive Summary
SLA Pharma's free fatty acid form of eicosapentaenoic acid (EPA), Alfa, has achieved statistically significant reductions in the number and size of colonic polyps in a late-stage clinical study in patients with familial adenomatous polyposis (FAP).